BCMA/CD19 Dual-Target CAR-T
PGC0008
Phase 1 mab active
Quick answer
BCMA/CD19 Dual-Target CAR-T for Multiple Myeloma is a Phase 1 program (mab) at Xijing Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xijing Hospital
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- active